Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 13NETWORK 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 6Breast Neoplasms 6Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Hepatocellular 3Small Cell Lung Carcinoma 2Lung Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Trauma, Nervous System 1Thoracic Injuries 1Stomach Neoplasms 1Skin Neoplasms 1Rectal Neoplasms 1Radiculopathy 1Pneumonia 1Pathologic Complete Response 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lymphoma 1Lung Diseases, Interstitial 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, B-Cell 1Leukemia 1Laryngeal Neoplasms 1Klippel-Feil Syndrome 1

Interventions

Bevacizumab 187Fluorouracil 150Leucovorin 135Cetuximab 127Irinotecan 114Oxaliplatin 108pembrolizumab 96Capecitabine 82IFL protocol 53Panitumumab 43Nivolumab 43regorafenib 42Folfox protocol 39Gemcitabine 30trifluridine tipiracil drug combination 27Cisplatin 24Carboplatin 24atezolizumab 23Pemetrexed 20Paclitaxel 20Drug Therapy 20130-nm albumin-bound paclitaxel 17Trastuzumab 14encorafenib 13Trifluridine 13Ipilimumab 13HMPL-013 13tislelizumab 12spartalizumab 11Docetaxel 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Colorectal Neoplasms × Observation × Clear all
NCT05234177 2025-05-06

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Tempus AI

Recruiting
300 enrolled
Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡